Page 340 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 340
EU Public Health (Cont.)
P1281 HEPATOLOGICAL MANIFESTATION OF DENGUE VIRAL
FEVER - A CLINICO BIOCHEMICAL STUDY IN ADULT
PATIENTS
Debnandan Chowdhury*, Prerna Bardhan, India
P1282 WHAT IS NEEDED TO CONTROL HEPATITIS C (HCV) IN
DIFFERENT EPIDEMIOLOGICAL SETTINGS?
Hannah Woodall*, Natasha Martin, Tim Hallett, Graham Cooke,
Matthew Hickman, Peter Vickerman, The United Kingdom
P1283 HEALTH RELATED QUALITY OF LIFE IN CIRRHOTIC
PATIENTS IN AUSTRIA
Annemarie Pickl, Birgit Hofmann-Bichler, Robert Buder, Peter Piringer,
Kurt Lenz*, Austria
P1284 ESTABLISHMENT OF AN INTERDISCIPLINARY ONLINE
EXPERT-FORUM (INXFO) SPECIALIZED IN HIV AND
ePOSTERS HEPATITIS IN GERMANY - UP-DATE 2014
Nikola Hanhoff, Patrick Braun, Patrick Ingiliz, Tim Kümmerle,
Stefan Preis, Jürgen Rockstroh, Eva Wolf, Christoph Wyen,
Leonie Meemken*, Germany
P1285 FORECASTING THE DISEASE BURDEN OF CHRONIC
HEPATITIS C IN RUSSIA
Vladimir Chulanov*, Olga Sagalova, Natalia Blokhina, Nina Mamonova,
Elena Nurmukhametova, Nikolay Pimenov, Aza Rakhmanova,
Homie Razavi, Kathryn Razavi-Shearer, Anatoly Shevaldin,
Eugene Chesnokov, Sergey Sokolov, Elena Strebkova, Olga Znoiko,
Irina Shestakova, Russia
TOP 10% LOW PREVALENCE OF POSITIVE VIRAL SEROLOGY FOR
YI P1286 HBV AND HCV AMONG A GENERAL DUTCH ELDERLY
POPULATION: RESULTS FROM THE ROTTERDAM STUDY
Elisabeth P. Plompen*, Raoel Maan, Robert J. de Knegt, Pavel Taimr,
Albert Hofman, Bruno H. Stricker, Sarwa Darwish Murad,
Harry L. Janssen, The Netherlands
TOP 10% PHYLOGENETIC ANALYSIS OF AN EPIDEMIC OUTBREAK
YI P1287 OF ACUTE HEPATITIS C IN HIV-INFECTED PATIENTS BY
MASSIVE SEQUENCING
Noelia Caro Pérez*, María Martinez-Rebollar, Josep Gregori, Josep Quer,
Patricia González, Martina Gambato, Hannah Visser, Juan I. Esteban,
Josep Mallolas, Xavier Forns, Sofía Pérez-del-Pulgar, Montserrat Laguno,
Spain
340 The International Liver Congress™ 2015 • ILC Programme
P1281 HEPATOLOGICAL MANIFESTATION OF DENGUE VIRAL
FEVER - A CLINICO BIOCHEMICAL STUDY IN ADULT
PATIENTS
Debnandan Chowdhury*, Prerna Bardhan, India
P1282 WHAT IS NEEDED TO CONTROL HEPATITIS C (HCV) IN
DIFFERENT EPIDEMIOLOGICAL SETTINGS?
Hannah Woodall*, Natasha Martin, Tim Hallett, Graham Cooke,
Matthew Hickman, Peter Vickerman, The United Kingdom
P1283 HEALTH RELATED QUALITY OF LIFE IN CIRRHOTIC
PATIENTS IN AUSTRIA
Annemarie Pickl, Birgit Hofmann-Bichler, Robert Buder, Peter Piringer,
Kurt Lenz*, Austria
P1284 ESTABLISHMENT OF AN INTERDISCIPLINARY ONLINE
EXPERT-FORUM (INXFO) SPECIALIZED IN HIV AND
ePOSTERS HEPATITIS IN GERMANY - UP-DATE 2014
Nikola Hanhoff, Patrick Braun, Patrick Ingiliz, Tim Kümmerle,
Stefan Preis, Jürgen Rockstroh, Eva Wolf, Christoph Wyen,
Leonie Meemken*, Germany
P1285 FORECASTING THE DISEASE BURDEN OF CHRONIC
HEPATITIS C IN RUSSIA
Vladimir Chulanov*, Olga Sagalova, Natalia Blokhina, Nina Mamonova,
Elena Nurmukhametova, Nikolay Pimenov, Aza Rakhmanova,
Homie Razavi, Kathryn Razavi-Shearer, Anatoly Shevaldin,
Eugene Chesnokov, Sergey Sokolov, Elena Strebkova, Olga Znoiko,
Irina Shestakova, Russia
TOP 10% LOW PREVALENCE OF POSITIVE VIRAL SEROLOGY FOR
YI P1286 HBV AND HCV AMONG A GENERAL DUTCH ELDERLY
POPULATION: RESULTS FROM THE ROTTERDAM STUDY
Elisabeth P. Plompen*, Raoel Maan, Robert J. de Knegt, Pavel Taimr,
Albert Hofman, Bruno H. Stricker, Sarwa Darwish Murad,
Harry L. Janssen, The Netherlands
TOP 10% PHYLOGENETIC ANALYSIS OF AN EPIDEMIC OUTBREAK
YI P1287 OF ACUTE HEPATITIS C IN HIV-INFECTED PATIENTS BY
MASSIVE SEQUENCING
Noelia Caro Pérez*, María Martinez-Rebollar, Josep Gregori, Josep Quer,
Patricia González, Martina Gambato, Hannah Visser, Juan I. Esteban,
Josep Mallolas, Xavier Forns, Sofía Pérez-del-Pulgar, Montserrat Laguno,
Spain
340 The International Liver Congress™ 2015 • ILC Programme
